Development
Cardinal Health, Inc.
CAH
$164.82
-$0.58-0.35%
NYSE
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 4.90% | 2.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.90% | 2.45% | |||
| Cost of Revenue | 4.91% | 2.65% | |||
| Gross Profit | 4.41% | -3.23% | |||
| SG&A Expenses | 7.18% | -5.52% | |||
| Depreciation & Amortization | -1.56% | -7.25% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.96% | 2.44% | |||
| Operating Income | -1.38% | 3.26% | |||
| Income Before Tax | 1,984.62% | -121.49% | |||
| Income Tax Expenses | 525.00% | -117.11% | |||
| Earnings from Continuing Operations | 5,800.00% | 109.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -150.00% | |||
| Net Income | 6,960.00% | 107.81% | |||
| EBIT | -1.38% | 3.26% | |||
| EBITDA | -0.59% | 1.80% | |||
| EPS Basic | 7,068.16% | 107.98% | |||
| Normalized Basic EPS | 4.30% | 5.25% | |||
| EPS Diluted | 7,050.00% | 107.94% | |||
| Normalized Diluted EPS | 4.30% | 4.83% | |||
| Average Basic Shares Outstanding | -1.61% | -1.97% | |||
| Average Diluted Shares Outstanding | -1.60% | -1.57% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.99% | 14.31% | |||